Agepha Pharma

Agepha Pharma is a leading multinational pharmaceutical company with a wide range of products. Over 70 years of continuous research and development of innovative products allows us to take pride in offering classic, well-established, safe, and affordable medications. Lodoco, a drug developed by Agepha Pharma, serves as an anti-inflammatory cardiovascular therapy for the prevention of atherosclerosis (atheroprotective), reducing the risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adult patients. Lodoco is also the first anti-inflammatory drug approved by the FDA for cardiovascular disease.